2019年12月以来，全球多地出现新型冠状病毒肺炎（COVID-19）病例，且数量激增，疫情形势非常严峻。国内在中医药的参与下，疫情防控效果显著，彰显了中医药的独特优势。COVID-19重症症状与中医胸痹症极为吻合，而瓜蒌薤白半夏汤是治疗胸痹症的要药，该方或其化裁方在多个省市新冠肺炎诊疗方案被推荐。在临床实践中，襄阳市中西医结合医院对瓜蒌薤白半夏汤进行加减化裁，治愈了多名新冠肺炎重症患者。主要对瓜蒌薤白半夏汤的现代药理作用进行综述，为其防治COVID-19提供理论依据，为后期治疗COVID-19提供临床参考。

Since December 2019, COVID-19 cases have appeared in many parts of the world and the number has soared. The epidemic situation is very serious. With the participation of traditional Chinese medicine in China, the epidemic prevention and control effect is remarkable, highlighting the unique advantages of traditional Chinese medicine. The symptoms of severe COVID-19 are very consistent with that of chest discomfort in Chinese medicine. Gualou Xiebai Banxia decoction is the first choice for the treatment of chest discomfort. In the diagnosis and treatment programs of COVID-19 in various provinces and cities, it has been recommended to add or subtracted Gualou Xiebai Banxia decoction. In clinical practice, XiangYang Hospital of Traditional Chinese and Western Medicine has added or subtracted Gualou Xiebai Banxia decoction to cure many patients with COVID-19. The modern pharmacological effects in Gualou Xiebai Banxia decoction are reviewed in this paper, to provide theoretical basis for its prevention and treatment of COVID-19, and to provide clinical reference for the later treatment of COVID-19.

R285.5;R286.4